Study of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB029, in Previously Treated Pediatric Participants With Hemophilia B

NCT01440946 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia B

Interventions

DRUG: rFIXFc
DRUG: FIX

Sponsor

Bioverativ Therapeutics Inc.

Collaborators

[object Object]